688278 特宝生物
已收盘 03-20 15:00:01
资讯
新帖
简况
每周股票复盘：特宝生物（688278）现两笔大宗交易合计近6844万
证券之星 · 03-22 03:43
每周股票复盘：特宝生物（688278）现两笔大宗交易合计近6844万
3月18日特宝生物现1笔折价19.17%的大宗交易 合计成交3653.44万元
证券之星 · 03-18
3月18日特宝生物现1笔折价19.17%的大宗交易 合计成交3653.44万元
3月17日特宝生物现1笔折价19.28%的大宗交易 合计成交3190.51万元
证券之星 · 03-17
3月17日特宝生物现1笔折价19.28%的大宗交易 合计成交3190.51万元
股市必读：3月13日特宝生物现1笔大宗交易 机构净卖出806.3万元
证券之星 · 03-16
股市必读：3月13日特宝生物现1笔大宗交易 机构净卖出806.3万元
每周股票复盘：特宝生物（688278）董事长提议1亿至2亿元回购股份
证券之星 · 03-15
每周股票复盘：特宝生物（688278）董事长提议1亿至2亿元回购股份
3月13日特宝生物现1笔大宗交易 机构净卖出806.3万元
中金财经 · 03-13
3月13日特宝生物现1笔大宗交易 机构净卖出806.3万元
特宝生物(688278.SH)董事长提议以1亿元至2亿元回购公司股份
智通财经 · 03-12
特宝生物(688278.SH)董事长提议以1亿元至2亿元回购公司股份
每周股票复盘：特宝生物（688278）2025年净利增25.39%
证券之星 · 02-15
每周股票复盘：特宝生物（688278）2025年净利增25.39%
特宝生物：2025年业绩稳健增长 “益佩生”打造第二增长曲线
中金财经 · 02-11
特宝生物：2025年业绩稳健增长 “益佩生”打造第二增长曲线
2月11日特宝生物涨6.01%，东方红睿丰LOF基金重仓该股
证券之星 · 02-11
2月11日特宝生物涨6.01%，东方红睿丰LOF基金重仓该股
特宝生物2025年初步净利润同比增长25.4%
投资观察 · 02-10
特宝生物2025年初步净利润同比增长25.4%
特宝生物发布2025年度业绩快报，盈利10.377亿元
证券之星 · 02-10
特宝生物发布2025年度业绩快报，盈利10.377亿元
国金证券：给予特宝生物买入评级，目标价92.74元
证券之星 · 02-10
国金证券：给予特宝生物买入评级，目标价92.74元
特宝生物（688278）披露向不特定对象发行可转换公司债券相关议案，2月3日股价上涨0.53%
证券之星 · 02-03
特宝生物（688278）披露向不特定对象发行可转换公司债券相关议案，2月3日股价上涨0.53%
特宝生物（688278）披露获得第九批国家级制造业单项冠军企业认定，1月29日股价下跌0.54%
证券之星 · 01-29
特宝生物（688278）披露获得第九批国家级制造业单项冠军企业认定，1月29日股价下跌0.54%
1月27日特宝生物发生1笔大宗交易 成交金额836万元
证券之星 · 01-27
1月27日特宝生物发生1笔大宗交易 成交金额836万元
特宝生物(688278.SH)拟发行可转债募资不超15.33亿元
智通财经 · 01-26
特宝生物(688278.SH)拟发行可转债募资不超15.33亿元
每周股票复盘：特宝生物（688278）两日现大宗交易超1454万元
证券之星 · 01-25
每周股票复盘：特宝生物（688278）两日现大宗交易超1454万元
1月23日特宝生物现758.8万元大宗交易
证券之星 · 01-23
1月23日特宝生物现758.8万元大宗交易
1月22日特宝生物发生1笔大宗交易 成交金额695.33万元
证券之星 · 01-22
1月22日特宝生物发生1笔大宗交易 成交金额695.33万元
加载更多
公司概况
公司名称：
厦门特宝生物工程股份有限公司
所属行业：
医药制造业
上市日期：
2020-01-17
主营业务：
厦门特宝生物工程股份有限公司的主营业务是重组蛋白质及其长效修饰药物研发、生产和销售。公司的主要产品是派格宾、益佩生、珮金、特尔立、特尔津、特尔康、愈适达。公司产品荣膺国家重大新药创制科技重大专项成果，成功入选“2023年度中国医药生物技术十大进展”，获评“2024年度药物创新成就奖”。
发行价格：
8.24
{"stockData":{"symbol":"688278","market":"SH","secType":"STK","nameCN":"特宝生物","latestPrice":66.66,"timestamp":1773990001000,"preClose":67.74,"halted":0,"volume":1676464,"delay":0,"changeRate":-0.0159,"floatShares":408000000,"shares":408000000,"eps":2.3019,"marketStatus":"已收盘","change":-1.08,"latestTime":"03-20 15:00:01","open":67.85,"high":68.5,"low":66.62,"amount":113000000,"amplitude":0.0278,"askPrice":66.7,"askSize":123,"bidPrice":66.66,"bidSize":53,"shortable":0,"etf":0,"ttmEps":2.3019,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1774229400000},"marketStatusCode":5,"adr":0,"adjPreClose":67.74,"symbolType":"stock_kcb","openAndCloseTimeList":[[1773970200000,1773977400000],[1773982800000,1773990000000]],"highLimit":74.51,"lowLimit":60.97,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":408189480,"isCdr":false,"pbRate":9.04,"roa":"--","peRate":28.958686,"roe":"23.82%","epsLYR":2.03,"committee":-0.031785,"marketValue":27210000000,"turnoverRate":0.0041,"status":1,"afterMarket":{"amount":0,"volume":0,"close":66.66,"buyVolume":0,"sellVolume":0,"time":1773992037559,"indexStatus":"已收盘 03-20 15:30:00","preClose":67.74},"floatMarketCap":27210000000},"requestUrl":"/m/hq/s/688278","defaultTab":"news","newsList":[{"id":"2621605791","title":"每周股票复盘：特宝生物（688278）现两笔大宗交易合计近6844万","url":"https://stock-news.laohu8.com/highlight/detail?id=2621605791","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621605791?lang=zh_cn&edition=full","pubTime":"2026-03-22 03:43","pubTimestamp":1774122190,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，特宝生物报收于66.66元，较上周的70.79元下跌5.83%。本周，特宝生物3月17日盘中最高价报71.21元。3月20日盘中最低价报66.62元，股价触及近一年最低点。特宝生物当前最新总市值272.1亿元，在生物制品板块市值排名10/51，在两市A股市值排名752/5190。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200001431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2620986239","title":"3月18日特宝生物现1笔折价19.17%的大宗交易 合计成交3653.44万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620986239","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620986239?lang=zh_cn&edition=full","pubTime":"2026-03-18 17:20","pubTimestamp":1773825658,"startTime":"0","endTime":"0","summary":"证券之星消息，3月18日特宝生物发生大宗交易，交易数据如下：近三个月该股共发生9笔大宗交易，合计成交1.93万手，折价成交2笔，溢价成交1笔。该股近期无解禁股上市。截至2026年3月18日收盘，特宝生物(688278)报收于69.01元，下跌1.0%，换手率0.29%，成交量1.17万手，成交额8069.27万元。该股最近90天内共有3家机构给出评级，买入评级3家；过去90天内机构目标均价为88.47。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031800029953.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2620440103","title":"3月17日特宝生物现1笔折价19.28%的大宗交易 合计成交3190.51万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2620440103","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620440103?lang=zh_cn&edition=full","pubTime":"2026-03-17 17:20","pubTimestamp":1773739228,"startTime":"0","endTime":"0","summary":"证券之星消息，3月17日特宝生物发生大宗交易，交易数据如下：大宗交易成交价格56.27元，相对当日收盘价折价19.28%，成交56.7万股，成交金额3190.51万元，买方营业部为广发证券股份有限公司厦门东黄路证券营业部，卖方营业部为广发证券股份有限公司晋江崇德路证券营业部。近三个月该股共发生8笔大宗交易，合计成交1.33万手，折价成交1笔。截至2026年3月17日收盘，特宝生物报收于69.71元，下跌0.88%，换手率0.41%，成交量1.69万手，成交额1.19亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700029850.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2619748813","title":"股市必读：3月13日特宝生物现1笔大宗交易 机构净卖出806.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619748813","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619748813?lang=zh_cn&edition=full","pubTime":"2026-03-16 03:10","pubTimestamp":1773601823,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，特宝生物报收于70.79元，上涨2.71%，换手率0.72%，成交量2.94万手，成交额2.08亿元。交易信息汇总资金流向3月13日主力资金净流入213.24万元，占总成交额1.03%；游资资金净流出605.49万元，占总成交额2.91%；散户资金净流入392.25万元，占总成交额1.89%。大宗交易3月13日特宝生物现1笔大宗交易，机构净卖出806.3万元。回购期限为股东会审议通过之日起12个月内。孙黎先生在提议前6个月内曾因股权激励获得48,000股归属，无其他买卖股份行为。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031600001194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2619178607","title":"每周股票复盘：特宝生物（688278）董事长提议1亿至2亿元回购股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2619178607","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619178607?lang=zh_cn&edition=full","pubTime":"2026-03-15 02:57","pubTimestamp":1773514628,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，特宝生物报收于70.79元，较上周的71.5元下跌0.99%。本周，特宝生物3月10日盘中最高价报71.42元。来自公司公告汇总：董事长提议以1亿至2亿元回购股份，用于员工持股、股权激励或转股。交易信息汇总3月13日特宝生物发生1笔大宗交易，机构净卖出806.3万元。其承诺将推动董事会和股东会审议回购事项并投赞成票。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000859.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2619984541","title":"3月13日特宝生物现1笔大宗交易 机构净卖出806.3万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2619984541","media":"中金财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619984541?lang=zh_cn&edition=full","pubTime":"2026-03-13 17:32","pubTimestamp":1773394334,"startTime":"0","endTime":"0","summary":"证券之星消息，3月13日特宝生物发生大宗交易，交易数据如下：大宗交易成交价格70.79元，成交11.39万股，成交金额806.3万元，买方营业部为瑞银证券有限责任公司上海花园石桥路证券营业部，卖方营业部为机构专用。近三个月该股共发生7笔大宗交易，合计成交7656.0手。截至2026年3月13日收盘，特宝生物报收于70.79元，上涨2.71%，换手率0.72%，成交量2.94万手，成交额2.08亿元。该股最近90天内共有3家机构给出评级，买入评级3家；过去90天内机构目标均价为88.47。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260313/32066847.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2618137315","title":"特宝生物(688278.SH)董事长提议以1亿元至2亿元回购公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2618137315","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618137315?lang=zh_cn&edition=full","pubTime":"2026-03-12 21:28","pubTimestamp":1773322113,"startTime":"0","endTime":"0","summary":"智通财经APP讯，特宝生物(688278.SH)发布公告，公司董事会于2026年3月12日收到公司董事长孙黎先生关于《提议厦门特宝生物工程股份有限公司回购公司股份的函》，孙黎先生提议公司使用自有资金和自筹资金通过上海证券交易所系统以集中竞价交易方式回购公司已发行的部分人民币普通股(A股)股票，回购股份的资金总额：不低于1亿元(含)，且不超过2亿元(含)，回购股份价格不超过85元/股(含)，回购股份的用途：在未来适宜时机用于实施员工持股计划及/或股权激励，或用于转换公司发行的可转换为股票的公司债券。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413304.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"特宝生物(688278.SH)董事长提议以1亿元至2亿元回购公司股份","news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2611536145","title":"每周股票复盘：特宝生物（688278）2025年净利增25.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2611536145","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2611536145?lang=zh_cn&edition=full","pubTime":"2026-02-15 02:04","pubTimestamp":1771092256,"startTime":"0","endTime":"0","summary":"截至2026年2月13日收盘，特宝生物报收于72.39元，较上周的69.11元上涨4.75%。本周，特宝生物2月11日盘中最高价报74.2元。2月9日盘中最低价报68.41元。特宝生物当前最新总市值295.49亿元，在生物制品板块市值排名10/51，在两市A股市值排名735/5189。业绩披露要点业绩快报特宝生物近日即将发布2025年年报，根据2月10日发布的业绩快报，归属净利润盈利10.377亿元，同比增长25.39%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021500000606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2610847934","title":"特宝生物：2025年业绩稳健增长 “益佩生”打造第二增长曲线","url":"https://stock-news.laohu8.com/highlight/detail?id=2610847934","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610847934?lang=zh_cn&edition=full","pubTime":"2026-02-11 19:50","pubTimestamp":1770810602,"startTime":"0","endTime":"0","summary":"近日，厦门特宝生物工程股份有限公司发布2025年度业绩快报。全新增长引擎：长效生长激素“益佩生”上市即放量2025年该公司业绩的新亮点来自新产品“益佩生”。国金证券将“益佩生”视为该公司的“第二增长曲线”。国金证券认为，尽管2025年第三季度因益佩生上市推广导致销售费用短期上升，利润增速承压，但随着该产品正式纳入医保并加速进院，以及派格宾治愈适应症的市场教育深化，特宝生物2026年业绩增长有望换挡提速。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260211/32012948.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2610984008","title":"2月11日特宝生物涨6.01%，东方红睿丰LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2610984008","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610984008?lang=zh_cn&edition=full","pubTime":"2026-02-11 16:31","pubTimestamp":1770798709,"startTime":"0","endTime":"0","summary":"证券之星消息，2月11日特宝生物涨6.01%，收盘报73.0元，换手率1.24%，成交量5.05万手，成交额3.67亿元。重仓特宝生物的前十大公募基金请见下表：该股最近90天内共有3家机构给出评级，买入评级3家。根据2025基金年报公募基金重仓股数据，重仓该股的公募基金共25家，其中持有数量最多的公募基金为东方红资产管理的东方红睿丰LOF。东方红睿丰LOF目前规模为21.43亿元，最新净值2.155，较上一交易日下跌0.14%，近一年上涨61.54%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021100025703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"1175116033","title":"特宝生物2025年初步净利润同比增长25.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1175116033","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1175116033?lang=zh_cn&edition=full","pubTime":"2026-02-10 20:13","pubTimestamp":1770725635,"startTime":"0","endTime":"0","summary":"厦门特宝生物股份有限公司（股票代码：688278）近日公布的初步财务数据显示，公司2025年净利润预计实现同比增长25.4%。这一业绩表现凸显了公司在生物科技领域的稳健增长势头。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2610532644","title":"特宝生物发布2025年度业绩快报，盈利10.377亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610532644","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610532644?lang=zh_cn&edition=full","pubTime":"2026-02-10 19:40","pubTimestamp":1770723632,"startTime":"0","endTime":"0","summary":"证券之星消息，特宝生物近日即将发布2025年年报，根据2月10日发布的业绩快报，归属净利润盈利10.377亿元，同比增长25.39%。实现营业总收入 369,556.72 万元，同比增长 31.18%；实现归属于母公司所有者的净利润 103,773.40 万元，同比增长 25.39%；实现归属于母公司所有者的扣除非经常性损益的净利润 106,749.22万元，同比增长 29.09%。报告期末公司总资产为 436,855.25 万元，较报告期期初增长 43.21%；归属于母公司的所有者权益 345,607.64 万元，较报告期初增长 35.36%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021000034193.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2610926316","title":"国金证券：给予特宝生物买入评级，目标价92.74元","url":"https://stock-news.laohu8.com/highlight/detail?id=2610926316","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610926316?lang=zh_cn&edition=full","pubTime":"2026-02-10 12:14","pubTimestamp":1770696895,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司甘坛焕,马居东近期对特宝生物进行研究并发布了研究报告《PEG长效药物领军企业，益佩生打造第二增长曲线》，给予特宝生物买入评级，目标价92.74元。派格宾收入从2016年0.7亿快速增长至2024年的24.5亿，并仍呈持续放量增长。给予公司26年27倍PE估值，目标市值379亿元，目标价92.74元，给予“买入”评级。最新盈利预测明细如下：该股最近90天内共有3家机构给出评级，买入评级3家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021000017365.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278"],"gpt_icon":0},{"id":"2608870360","title":"特宝生物（688278）披露向不特定对象发行可转换公司债券相关议案，2月3日股价上涨0.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608870360","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608870360?lang=zh_cn&edition=full","pubTime":"2026-02-03 22:48","pubTimestamp":1770130099,"startTime":"0","endTime":"0","summary":"截至2026年2月3日收盘，特宝生物报收于74.6元，较前一交易日上涨0.53%，最新总市值为304.51亿元。该股当日开盘74.47元，最高75.55元，最低73.77元，成交额达1亿元，换手率为0.33%。本次发行募集资金总额不超过153,326.69万元，用于新药研发、生物技术创新融合中心建设及创新药物生产改扩项目。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300043492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2607806036","title":"特宝生物（688278）披露获得第九批国家级制造业单项冠军企业认定，1月29日股价下跌0.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2607806036","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2607806036?lang=zh_cn&edition=full","pubTime":"2026-01-29 22:47","pubTimestamp":1769698031,"startTime":"0","endTime":"0","summary":"截至2026年1月29日收盘，特宝生物报收于75.99元，较前一交易日下跌0.54%，最新总市值为310.18亿元。该股当日开盘76.01元，最高76.99元，最低75.73元，成交额达1.15亿元，换手率为0.37%。近日，厦门特宝生物工程股份有限公司发布公告称，公司于近日获得工业和信息化部颁发的《制造业单项冠军企业证书》，被认定为第九批制造业单项冠军企业，凭借聚乙二醇干扰素α-2b注射液的产品技术优势和市场地位。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012900043917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2606207696","title":"1月27日特宝生物发生1笔大宗交易 成交金额836万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606207696","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606207696?lang=zh_cn&edition=full","pubTime":"2026-01-27 17:37","pubTimestamp":1769506622,"startTime":"0","endTime":"0","summary":"证券之星消息，1月27日特宝生物发生大宗交易，交易数据如下：大宗交易成交价格76元，成交11万股，成交金额836万元，买方营业部为中信证券股份有限公司总部，卖方营业部为广发证券股份有限公司广州花城大道证券营业部。近三个月该股共发生8笔大宗交易，合计成交7097.0手。该股近期无解禁股上市。截至2026年1月27日收盘，特宝生物报收于76.0元，上涨1.36%，换手率0.54%，成交量2.2万手，成交额1.68亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012700029973.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2606263243","title":"特宝生物(688278.SH)拟发行可转债募资不超15.33亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606263243","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606263243?lang=zh_cn&edition=full","pubTime":"2026-01-26 21:35","pubTimestamp":1769434512,"startTime":"0","endTime":"0","summary":"智通财经APP讯，特宝生物(688278.SH)发布公告，公司拟向不特定对象发行可转债，募集资金总额(含发行费用)不超过15.33亿元(含本数)，扣除发行费用后的募集资金净额将用于：新药研发项目、生物技术创新融合中心建设项目、特宝生物创新药物生产改扩项目-产线建设。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1397593.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2606623247","title":"每周股票复盘：特宝生物（688278）两日现大宗交易超1454万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606623247","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606623247?lang=zh_cn&edition=full","pubTime":"2026-01-25 02:55","pubTimestamp":1769280910,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，特宝生物报收于75.88元，较上周的75.9元下跌0.03%。本周，特宝生物1月21日盘中最高价报79.8元。1月20日盘中最低价报74.72元。特宝生物当前最新总市值309.73亿元，在生物制品板块市值排名10/51，在两市A股市值排名710/5182。本周关注点来自交易信息汇总：1月22日至23日，特宝生物连续两日发生大宗交易，合计成交额达1454.13万元。1月22日，特宝生物发生1笔大宗交易，成交金额为695.33万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500000959.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0},{"id":"2605475730","title":"1月23日特宝生物现758.8万元大宗交易","url":"https://stock-news.laohu8.com/highlight/detail?id=2605475730","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605475730?lang=zh_cn&edition=full","pubTime":"2026-01-23 17:49","pubTimestamp":1769161760,"startTime":"0","endTime":"0","summary":"证券之星消息，1月23日特宝生物发生大宗交易，交易数据如下：大宗交易成交价格75.88元，成交10万股，成交金额758.8万元，买方营业部为中信证券股份有限公司总部，卖方营业部为广发证券股份有限公司郑州航海东路证券营业部。近三个月该股共发生7笔大宗交易，合计成交5997.0手。该股近期无解禁股上市。截至2026年1月23日收盘，特宝生物报收于75.88元，下跌0.69%，换手率0.55%，成交量2.25万手，成交额1.71亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300029907.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688278","BK0239"],"gpt_icon":0},{"id":"2605464630","title":"1月22日特宝生物发生1笔大宗交易 成交金额695.33万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2605464630","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605464630?lang=zh_cn&edition=full","pubTime":"2026-01-22 17:43","pubTimestamp":1769075035,"startTime":"0","endTime":"0","summary":"证券之星消息，1月22日特宝生物发生大宗交易，交易数据如下：大宗交易成交价格76.41元，成交9.1万股，成交金额695.33万元，买方营业部为国泰海通证券股份有限公司总部，卖方营业部为国泰海通证券股份有限公司总部。近三个月该股共发生6笔大宗交易，合计成交4997.0手。截至2026年1月22日收盘，特宝生物报收于76.41元，下跌2.2%，换手率0.52%，成交量2.13万手，成交额1.63亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012200029380.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688278"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1774223318682,"stockEarnings":[{"period":"1week","weight":-0.0583},{"period":"1month","weight":-0.0792},{"period":"3month","weight":-0.2158},{"period":"6month","weight":-0.1575},{"period":"1year","weight":-0.1763},{"period":"ytd","weight":-0.2034}],"compareEarnings":[{"period":"1week","weight":-0.0338},{"period":"1month","weight":-0.0306},{"period":"3month","weight":0.0171},{"period":"6month","weight":0.0359},{"period":"1year","weight":0.1608},{"period":"ytd","weight":-0.003}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"厦门特宝生物工程股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8608人(较上一季度增加2.00%)","perCapita":"47419股","listingDate":"2020-01-17","address":"福建省厦门市海沧区新阳工业区翁角路330号","registeredCapital":"40818万元","survey":" 厦门特宝生物工程股份有限公司的主营业务是重组蛋白质及其长效修饰药物研发、生产和销售。公司的主要产品是派格宾、益佩生、珮金、特尔立、特尔津、特尔康、愈适达。公司产品荣膺国家重大新药创制科技重大专项成果，成功入选“2023年度中国医药生物技术十大进展”，获评“2024年度药物创新成就奖”。","listedPrice":8.24},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"特宝生物(688278)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供特宝生物(688278)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"特宝生物,688278,特宝生物股票,特宝生物股票老虎,特宝生物股票老虎国际,特宝生物行情,特宝生物股票行情,特宝生物股价,特宝生物股市,特宝生物股票价格,特宝生物股票交易,特宝生物股票购买,特宝生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"特宝生物(688278)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供特宝生物(688278)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}